Erfolgreiche Behandlung einer palmoplantaren Pustulose mit topischem Ruxolitinib
Open Access
- 11 December 2025
- journal article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 23 (12) , 1591-1593
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patientsFrontiers in Medicine, 2024
- Efficacy and Safety of JAK-Inhibitors in Treating Refractory Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis: A Systematic ReviewJournal of Cutaneous Medicine and Surgery, 2024
- Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case SeriesInfection and Drug Resistance, 2023
- Efficacy and safety of biological agents to treat patients with palmoplantar pustulosis: A systematic scoping reviewInternational Immunopharmacology, 2023
- Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigsInternational Journal of Pharmaceutics, 2020
- Successful therapy of palmoplantar pustulosis with tofacitinib—Report on three casesDermatologic Therapy, 2020
- European consensus statement on phenotypes of pustular psoriasisJournal of the European Academy of Dermatology and Venereology, 2017
- Palmoplantar pustulosis – a cross-sectional analysis in GermanyDermatology Online Journal, 2017